These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 21325671)

  • 1. Molecular mechanisms affecting fibrin structure and stability.
    Lord ST
    Arterioscler Thromb Vasc Biol; 2011 Mar; 31(3):494-9. PubMed ID: 21325671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma fibrin clot properties in the G20210A prothrombin mutation carriers following venous thromboembolism: the effect of rivaroxaban.
    Janion-Sadowska A; Natorska J; Siudut J; Ząbczyk M; Stanisz A; Undas A
    Thromb Haemost; 2017 Aug; 117(9):1739-1749. PubMed ID: 28771277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BβArg448Lys polymorphism is associated with altered fibrin clot structure and fibrinolysis in type 2 diabetes.
    Greenhalgh KA; Strachan MW; Alzahrani S; Baxter PD; Standeven KF; Storey RF; Ariens RA; Grant PJ; Price JF; Ajjan RA
    Thromb Haemost; 2017 Jan; 117(2):295-302. PubMed ID: 27929198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibrin(ogen) as a Therapeutic Target: Opportunities and Challenges.
    Gaule TG; Ajjan RA
    Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34203139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombotic dysfibrinogenemia. Fibrinogen "Caracas V" relation between very tight fibrin network and defective clot degradability.
    Marchi R; Mirshahi SS; Soria C; Mirshahi M; Zohar M; Collet JP; de Bosch NB; Arocha-Piñango CL; Soria J
    Thromb Res; 2000 Jul; 99(2):187-93. PubMed ID: 10946093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibrinogen, red blood cells, and factor XIII in venous thrombosis.
    Walton BL; Byrnes JR; Wolberg AS
    J Thromb Haemost; 2015 Jun; 13 Suppl 1(Suppl 1):S208-15. PubMed ID: 26149026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modification of fibrinogen by homocysteine thiolactone increases resistance to fibrinolysis: a potential mechanism of the thrombotic tendency in hyperhomocysteinemia.
    Sauls DL; Lockhart E; Warren ME; Lenkowski A; Wilhelm SE; Hoffman M
    Biochemistry; 2006 Feb; 45(8):2480-7. PubMed ID: 16489740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of fibrinogen carbamylation on fibrin clot formation and stability.
    Binder V; Bergum B; Jaisson S; Gillery P; Scavenius C; Spriet E; Nyhaug AK; Roberts HM; Chapple ILC; Hellvard A; Delaleu N; Mydel P
    Thromb Haemost; 2017 May; 117(5):899-910. PubMed ID: 28382370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clot properties and cardiovascular disease.
    Bridge KI; Philippou H; Ariëns R
    Thromb Haemost; 2014 Nov; 112(5):901-8. PubMed ID: 24899357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibrinogen and Fibrin in Hemostasis and Thrombosis.
    Kattula S; Byrnes JR; Wolberg AS
    Arterioscler Thromb Vasc Biol; 2017 Mar; 37(3):e13-e21. PubMed ID: 28228446
    [No Abstract]   [Full Text] [Related]  

  • 11. Fibrinopeptide A release is necessary for effective B:b interactions in polymerisation of variant fibrinogens with impaired A:a interactions.
    Soya K; Terasawa F; Okumura N
    Thromb Haemost; 2013 Feb; 109(2):221-8. PubMed ID: 23238100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanical and Biochemical Role of Fibrin Within a Venous Thrombus.
    Chandrashekar A; Singh G; Jonah Garry ; Sikalas N; Labropoulos N
    Eur J Vasc Endovasc Surg; 2018 Mar; 55(3):417-424. PubMed ID: 29336975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Probing the Dynamics of Clot-Bound Thrombin at Venous Shear Rates.
    Haynes LM; Orfeo T; Mann KG; Everse SJ; Brummel-Ziedins KE
    Biophys J; 2017 Apr; 112(8):1634-1644. PubMed ID: 28445754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of fibrin structure in thrombosis and vascular disease.
    Cilia La Corte AL; Philippou H; Ariëns RA
    Adv Protein Chem Struct Biol; 2011; 83():75-127. PubMed ID: 21570666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibrinogen and fibrin: scaffold proteins in hemostasis.
    Lord ST
    Curr Opin Hematol; 2007 May; 14(3):236-41. PubMed ID: 17414213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antithrombin-independent effects of heparins on fibrin clot nanostructure.
    Yeromonahos C; Marlu R; Polack B; Caton F
    Arterioscler Thromb Vasc Biol; 2012 May; 32(5):1320-4. PubMed ID: 22362760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant fibrinogen reveals the differential roles of α- and γ-chain cross-linking and molecular heterogeneity in fibrin clot strain-stiffening.
    Piechocka IK; Kurniawan NA; Grimbergen J; Koopman J; Koenderink GH
    J Thromb Haemost; 2017 May; 15(5):938-949. PubMed ID: 28166607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibrin clot structure - pro-fibrinolytic effect of oral contraceptives in apparently healthy women.
    Sidelmann JJ; Kluft C; Krug AH; Winkler U; Jespersen J; Gram JB
    Thromb Haemost; 2017 Apr; 117(4):700-705. PubMed ID: 28150855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two families of synthetic peptides that enhance fibrin turbidity and delay fibrinolysis by different mechanisms.
    Pandi L; Kollman JM; Lopez-Lira F; Burrows JM; Riley M; Doolittle RF
    Biochemistry; 2009 Aug; 48(30):7201-8. PubMed ID: 19588915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibrin clot formation and lysis: basic mechanisms.
    Sidelmann JJ; Gram J; Jespersen J; Kluft C
    Semin Thromb Hemost; 2000; 26(6):605-18. PubMed ID: 11140797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.